Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-19 · Built: 2026-10-19 · 中文

← United States · Coverage record

US · SEC FORM 4

Moderna, Inc.

MRNA · Nasdaq · CIK 0001682852 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

88 Form 4 transaction lines observed in the same window
18 sales · 70 option, withholding, award, gift or other lines

Last qualifying purchase2025-03-03 · Bancel Stephane · $5.0M

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Hoge StephenPresident
○▼○▼○○○○○○○▼○▼○▼○▼
Mock James MChief Financial Officer
○○○○○○○○○○○○○○○▼○○
Klinger Shannon ThymeChief Legal Officer
○○▼○○○○○○○○▼○○
Bancel StephaneChief Executive Officer
○▼○
● Purchase▼ Sale○ Other

—

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-03-03 · Bancel Stephane.

Recent Form 4 activity

0Purchases
22Sales
133Other Form 4 lines
54SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING18 sale line(s) · context only
OTHER70 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
30,863,202
Previous report
32,872,787
Avg daily volume
16,889,344
Days to cover
1.8

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-03-03SAGAN PAULPurchase (P)Common Stock31,620USD 31.76USD 1,004,251SEC filing ↗
2025-03-03Bancel StephanePurchase (P)Common Stock160,314USD 31.22USD 5,004,318SEC filing ↗
2020-02-14SAGAN PAULPurchase (P)Common Stock52,631USD 19.00USD 999,989SEC filing ↗

Form 4 evidence

155 transaction lines in the latest 365-day window; 3,808 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-15Hoge StephenSale (S)Common Stock39,145USD 220.72USD 8,640,084SEC filing ↗
2026-10-15Hoge StephenOption exercise / conversion (M)Common Stock76,452USD 12.21USD 933,479SEC filing ↗
2026-10-14Hoge StephenSale (S)Common Stock39,224USD 213.48USD 8,373,453SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-15Hoge StephenSale (S)Common Stock39,145USD 220.72USD 8,640,084SEC filing ↗
2026-10-15Hoge StephenOption exercise / conversion (M)Common Stock76,452USD 12.21USD 933,479SEC filing ↗
2026-10-14Hoge StephenSale (S)Common Stock39,224USD 213.48USD 8,373,453SEC filing ↗
2026-10-14Hoge StephenOption exercise / conversion (M)Common Stock76,453USD 12.21USD 933,491SEC filing ↗
2026-10-05Mock James MOption exercise / conversion (M)Common Stock1,454USD —USD —SEC filing ↗
2026-10-05Mock James MTax withholding (F)Common Stock704USD 190.01USD 133,767SEC filing ↗
2026-09-15Hoge StephenSale (S)Common Stock40,281USD 146.07USD 5,883,846SEC filing ↗
2026-09-15Hoge StephenOption exercise / conversion (M)Common Stock76,452USD 12.21USD 933,479SEC filing ↗
2026-09-14Hoge StephenSale (S)Common Stock40,294USD 144.13USD 5,807,574SEC filing ↗
2026-09-14Hoge StephenOption exercise / conversion (M)Common Stock76,453USD 12.21USD 933,491SEC filing ↗
2026-09-10Mock James MSale (S)Common Stock34,836USD 134.49USD 4,685,094SEC filing ↗
2026-09-10Mock James MOption exercise / conversion (M)Common Stock19,836USD 30.96USD 614,123SEC filing ↗
2026-09-04Mock James MOption exercise / conversion (M)Common Stock11,797USD —USD —SEC filing ↗
2026-09-04Mock James MTax withholding (F)Common Stock5,704USD 148.87USD 849,154SEC filing ↗
2026-09-04Klinger Shannon ThymeOption exercise / conversion (M)Common Stock11,797USD —USD —SEC filing ↗
2026-09-04Klinger Shannon ThymeTax withholding (F)Common Stock5,704USD 148.87USD 849,154SEC filing ↗
2026-09-01Mock James MOption exercise / conversion (M)Common Stock2,475USD —USD —SEC filing ↗
2026-09-01Mock James MTax withholding (F)Common Stock1,197USD 140.34USD 167,987SEC filing ↗
2026-09-01Klinger Shannon ThymeSale (S)Common Stock3,471USD 139.95USD 485,766SEC filing ↗
2026-09-01Klinger Shannon ThymeOption exercise / conversion (M)Common Stock5,637USD —USD —SEC filing ↗
2026-09-01Klinger Shannon ThymeTax withholding (F)Common Stock1,048USD 140.34USD 147,076SEC filing ↗
2026-09-01Hoge StephenOption exercise / conversion (M)Common Stock9,283USD —USD —SEC filing ↗
2026-09-01Hoge StephenTax withholding (F)Common Stock4,489USD 140.34USD 629,986SEC filing ↗
2026-08-28Mock James MOption exercise / conversion (M)Common Stock329USD —USD —SEC filing ↗
2026-08-28Mock James MTax withholding (F)Common Stock160USD 142.77USD 22,843SEC filing ↗
2026-08-28Klinger Shannon ThymeOption exercise / conversion (M)Common Stock329USD —USD —SEC filing ↗
2026-08-28Klinger Shannon ThymeTax withholding (F)Common Stock160USD 142.77USD 22,843SEC filing ↗
2026-08-28Hoge StephenOption exercise / conversion (M)Common Stock611USD —USD —SEC filing ↗
2026-08-28Hoge StephenTax withholding (F)Common Stock296USD 142.77USD 42,260SEC filing ↗
2026-08-27Mock James MOption exercise / conversion (M)Common Stock774USD —USD —SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-19
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerMRNA
CIK0001682852
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2836 Biological Products, (No Diagnostic Substances)
ExchangeNasdaq

Data coverage

Local Form 4 history3,808 transaction lines from 2020-01-02 to 2026-10-15
4 P purchase lines · 2,765 S sale lines · 1,039 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.